[go: up one dir, main page]

AU2002236626A1 - Compositions and methods for treating hyperpigmentation - Google Patents

Compositions and methods for treating hyperpigmentation

Info

Publication number
AU2002236626A1
AU2002236626A1 AU2002236626A AU3662602A AU2002236626A1 AU 2002236626 A1 AU2002236626 A1 AU 2002236626A1 AU 2002236626 A AU2002236626 A AU 2002236626A AU 3662602 A AU3662602 A AU 3662602A AU 2002236626 A1 AU2002236626 A1 AU 2002236626A1
Authority
AU
Australia
Prior art keywords
compositions
methods
treating hyperpigmentation
hyperpigmentation
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002236626A
Other languages
English (en)
Inventor
Chrostos D. Kyrou
Harish Mahalingam
Dmitri Ptchelintsev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avon Products Inc
Original Assignee
Avon Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products Inc filed Critical Avon Products Inc
Publication of AU2002236626A1 publication Critical patent/AU2002236626A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2002236626A 2000-12-20 2001-12-14 Compositions and methods for treating hyperpigmentation Abandoned AU2002236626A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09741383 2000-12-20
US09/741,383 US6562321B2 (en) 2000-12-20 2000-12-20 Compositions and methods for treating hyperpigmentation
PCT/US2001/048382 WO2002049580A1 (fr) 2000-12-20 2001-12-14 Compositions et methodes pour traiter l'hyperpigmentation

Publications (1)

Publication Number Publication Date
AU2002236626A1 true AU2002236626A1 (en) 2002-07-01

Family

ID=24980507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002236626A Abandoned AU2002236626A1 (en) 2000-12-20 2001-12-14 Compositions and methods for treating hyperpigmentation

Country Status (9)

Country Link
US (1) US6562321B2 (fr)
EP (1) EP1351647B1 (fr)
JP (1) JP2004516259A (fr)
CN (1) CN1274291C (fr)
AU (1) AU2002236626A1 (fr)
BR (1) BRPI0116293B1 (fr)
CA (1) CA2429935C (fr)
MX (1) MX246293B (fr)
WO (1) WO2002049580A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20090092561A1 (en) * 2007-10-09 2009-04-09 Lupia Joseph A Body-care and household products and compositions comprising specific sulfur-containing compounds
FR2928835B1 (fr) * 2008-03-20 2010-05-07 Nuxe Lab Composition depigmentante a base de crocus sativus.
CA2768653C (fr) * 2009-08-31 2019-03-05 Avon Products, Inc. Utilisations cosmetiques d'extraits modifies de levure stressee et compositions associees
CA2784899A1 (fr) 2009-12-30 2011-07-07 Avon Products, Inc. Composition eclaircissante topique et utilisations de celle-ci
CN102078486B (zh) * 2011-01-21 2012-06-20 吉林紫鑫药物研究有限公司 一种祛黄褐斑的药物组合物及其制备方法
US9023327B2 (en) * 2012-08-30 2015-05-05 Avon Products, Inc. DICKKOPF-1 expression modulating compositions and uses thereof
US10117821B2 (en) 2013-03-12 2018-11-06 Avon Products, Inc. Topical lightening composition and methods of use thereof
CN106102838A (zh) * 2014-06-02 2016-11-09 雅芳产品公司 局部用增亮组合物及其使用方法
ES2839503T3 (es) * 2016-05-29 2021-07-05 Scientis Sa Uso de derivados de tiofosfato como agentes despigmentantes de la piel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1000724A6 (fr) 1987-05-20 1989-03-21 Stiefel Lab Ltd Compositions a base de dithranol.
FR2639828B1 (fr) 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
JP2884466B2 (ja) * 1993-12-27 1999-04-19 長瀬産業株式会社 シソ抽出液、その製造方法およびそれを含有する美白化粧料
US6080393A (en) * 1994-07-09 2000-06-27 Johnson & Johnson Consumer Products, Inc. Skin care composition comprising a retinoid
FR2742750B1 (fr) 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
FR2773323B1 (fr) 1998-01-05 2000-02-11 Oreal Composition contenant une association de procysteine et de polyol
FR2778561B1 (fr) 1998-05-14 2001-04-20 Oreal Azurants optiques comme agents blanchissants
TW591026B (en) 1998-06-23 2004-06-11 Upjohn Co Inhibitors of alpha4beta1 mediated cell adhesion
DE19829789A1 (de) 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6087385A (en) * 1998-10-30 2000-07-11 University Of Mississippi Flavonoid derivatives
DE19929511C2 (de) * 1999-06-29 2003-04-10 Cognis Deutschland Gmbh Hochkonzentriert fließfähige Aniontensidmischungen
CA2413919A1 (fr) * 2000-03-21 2001-09-13 Avon Products, Inc. Methodes utilisant du phytol destinees a l'amelioration de l'apparence de la peau et compositions correspondantes
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation

Also Published As

Publication number Publication date
EP1351647B1 (fr) 2012-11-14
EP1351647A4 (fr) 2005-03-16
CA2429935C (fr) 2011-03-15
WO2002049580A1 (fr) 2002-06-27
MX246293B (es) 2007-06-08
BRPI0116293B1 (pt) 2016-07-12
EP1351647A1 (fr) 2003-10-15
JP2004516259A (ja) 2004-06-03
MXPA03005510A (es) 2004-04-20
CA2429935A1 (fr) 2002-06-27
US6562321B2 (en) 2003-05-13
CN1482892A (zh) 2004-03-17
BR0116293A (pt) 2004-08-17
CN1274291C (zh) 2006-09-13
US20020141953A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002219945A1 (en) Composition and method for treating snoring
AU2778801A (en) Antisense compositions and methods
AU2001253065A1 (en) Compositions and methods for treating hair loss using oximyl- and hydroxylamino-prostaglandins
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU6832101A (en) Composition and method
AU2001219651A1 (en) Mulch composition and method
AU2001280599A1 (en) Compounds and methods
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2001253418A1 (en) Compounds and methods
AU4163402A (en) Composition and method
AU2001286651A1 (en) Microparticle composition and method
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2001279850A1 (en) Method and arrangement for studsystem
AU4215901A (en) Methods and compositions for immunoregulation
AU2001243394A1 (en) Compounds and methods
AU2001294686A1 (en) Composition and process for treating metals
AUPQ872300A0 (en) Compounds and methods
AU2001233932A1 (en) Method and composition
AU2001278951A1 (en) Compounds and methods
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU2001238179A1 (en) Method and compositions for treating hepatocellular cancer
AU2001261513A1 (en) Composition and method for increasing testosterone levels
AU2002239775A1 (en) Chemical-library composition and method
AU2001243297A1 (en) Method for treating or preventing depression